24.02.2013 Views

annual report 2011 - Office for Research - Northwestern University

annual report 2011 - Office for Research - Northwestern University

annual report 2011 - Office for Research - Northwestern University

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Melina R. Kibbe<br />

Feinberg School of Medicine<br />

Stem Cells That Reside in the<br />

Arterial Wall May Control the<br />

Fate of Vascular Interventions<br />

Failure of vascular interventions, such as<br />

bypass grafting and balloon angioplasty<br />

and stenting, results from neointimal<br />

hyperplasia. Classically, this process has<br />

been thought to result from overgrowth of the cells<br />

that line the media—the middle layer of the arterial<br />

wall—and that ultimately leads to restenosis and arterial<br />

occlusion. In the last decade, however, this view has<br />

been changing, as it is now recognized that the arterial<br />

wall’s outer layer, the adventitial, may play a much<br />

more prominent role in this process. Specifically, the<br />

adventitia has been identified as home to a progenitor<br />

cell, the Sca1+ cell, which may be integral to the process<br />

of neointimal hyperplasia.<br />

Melina Kibbe, vascular surgery, has had a long-<br />

standing interest in the development and prevention<br />

of neointimal hyperplasia. Her ef<strong>for</strong>ts have focused on<br />

using nitric oxide as a therapeutic agent, given that nitric<br />

oxide is a potent inhibitor of neointimal hyperplasia.<br />

While studying the effects of nitric oxide on the<br />

vascular wall, Kibbe discovered that following vascular<br />

interventions, nitric oxide dramatically increases the<br />

Sca1+ progenitor cells residing in the adventitia just<br />

external to the external elastic lamina. Whether this<br />

increase elicited by nitric oxide is due to an increase in<br />

recruitment of these cells to the vascular wall following<br />

injury or due to inhibition of phenotypic differentiation<br />

of these cells to myofibroblasts, thereby preventing<br />

them from contributing to neointimal hyperplasia,<br />

remains to be determined.<br />

Kibbe was recently awarded a grant from the National<br />

Institutes of Health to study the role of Sca1+ cells<br />

following vascular interventions and nitric oxide therapy.<br />

Kibbe’s research has also been supported by grants from<br />

the Department of Veterans Affairs, the American Heart<br />

Association, the American Recovery and Reinvestment<br />

Act, and the <strong>Northwestern</strong> Memorial Foundation.<br />

Immuno�uorescent staining of Sca1+ cells in culture<br />

Balloon angioplasty Balloon angioplasty + nitric oxide<br />

Cross section of an artery that has undergone balloon angioplasty (left) and balloon angioplasty with<br />

nitric oxide exposure (right)<br />

Excellence in <strong>Research</strong> | Annual Report <strong>2011</strong> 39<br />

Andrew Campbell

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!